首页 › 基金 › DRIEHAUS CAPITAL MANAGEMENT LLC › DFTX
DRIEHAUS CAPITAL MANAGEMENT LLC 对 DFTX 的持仓历史
DEFINIUM THERAPEUTICS INC · 医疗保健
DRIEHAUS CAPITAL MANAGEMENT LLC 在 Q3 2026 的 13F 申报中披露持有 DFTX(DEFINIUM THERAPEUTICS INC)6,788,022 股,市值约 US$258.4M,约占其申报组合的 1.80%,在其申报持仓中市值排名第 2 位。 DRIEHAUS CAPITAL MANAGEMENT LLC 最近 4 个申报季度中有 4 个季度披露了 DFTX 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
DRIEHAUS CAPITAL MANAGEMENT LLC 对 DFTX 的持仓演变
DRIEHAUS CAPITAL MANAGEMENT LLC 于 Q4 2025 首次披露 DFTX 持仓:6,537,202 股(约 US$87.5M)。 该持仓在 Q2 2026 达到峰值 6,845,276 股,市值约 US$322.0M。 在 4 次申报中,DRIEHAUS CAPITAL MANAGEMENT LLC 1 次增持、2 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 6,788,022 股、市值约 US$258.4M,环比减持 -57,254 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 6.54M | $87.53M | 新进 |
| Q1 2026 | 5.91M | $111.73M | 减持 |
| Q2 2026 | 6.85M | $322.00M | 增持 |
| Q3 2026 | 6.79M | $258.35M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 DFTX 与 13F 数据
DFTX(DEFINIUM THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 133 只申报持有 DFTX,申报仓位最大的包括:Avoro Capital Advisors LLC (US$268.3M), Octagon Capital Advisors LP (US$138.8M), Commodore Capital LP (US$94.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 DFTX 的基金
- Avoro Capital Advisors LLC 7.05M 股 · $268.32M · Q3 2026
- Octagon Capital Advisors LP 2.95M 股 · $138.77M · Q2 2026
- Commodore Capital LP 2.00M 股 · $94.08M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.50M 股 · $70.56M · Q2 2026
- Boxer Capital Management, LLC 998.50K 股 · $46.97M · Q2 2026
- Deep Track Capital, LP 1.00M 股 · $38.06M · Q3 2026
- AWM Investment Company, Inc. 764.80K 股 · $29.11M · Q3 2026
- Catalio Capital Management, LP 562.67K 股 · $26.47M · Q2 2026
- GREAT POINT PARTNERS LLC 425.00K 股 · $19.99M · Q2 2026
- Integral Health Asset Management, LLC 500.00K 股 · $19.03M · Q3 2026
- Ally Bridge Group (NY) LLC 400.00K 股 · $18.82M · Q2 2026
- Cormorant Asset Management, LP 400.00K 股 · $18.82M · Q2 2026
更多关于 DRIEHAUS CAPITAL MANAGEMENT LLC
常见问题
How long has DRIEHAUS CAPITAL MANAGEMENT LLC held DFTX?
DRIEHAUS CAPITAL MANAGEMENT LLC has disclosed DFTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is DRIEHAUS CAPITAL MANAGEMENT LLC's current position in DFTX?
As of Q3 2026, DRIEHAUS CAPITAL MANAGEMENT LLC holds 6.79M shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $258.35M, representing 1.80% of its reported portfolio and ranking #2.
Has DRIEHAUS CAPITAL MANAGEMENT LLC been buying or selling DFTX?
In the latest 13F filing (Q3 2026), DRIEHAUS CAPITAL MANAGEMENT LLC reduced its position in DFTX. The position peaked in Q2 2026 at 6.85M shares.
Which other funds hold DFTX?
Other major institutional holders of DFTX include Avoro Capital Advisors LLC, Octagon Capital Advisors LP, Commodore Capital LP, among 133 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.